We've made it easier for you to connect! Fill out your NEW profile.
FDA Approves Keytruda for Early-Stage TNBC
moderators
Posts: 8,963
FDA Approves Keytruda for Early-Stage Triple-Negative Breast Cancer
July 27, 2021
The U.S. Food and Drug Administration (FDA) has approved Keytruda plus chemotherapy before surgery, followed by Keytruda alone after surgery to treat early-stage triple-negative breast cancer with a high risk of recurrence. Read more...
July 27, 2021
The U.S. Food and Drug Administration (FDA) has approved Keytruda plus chemotherapy before surgery, followed by Keytruda alone after surgery to treat early-stage triple-negative breast cancer with a high risk of recurrence. Read more...
0
Categories
Join Us on Zoom: Upcoming virtual support groups. Read more...
Share more about you! Fill out your NEW profile.